Inverness Medical Innovations to start roadshow Tuesday for $150 million eight-year notes

By Paul A. Harris

St. Louis, Jan. 22 - Inverness Medical Innovations plans to start a roadshow Tuesday for $150 million of senior subordinated notes due 2012, a market source said.

The deal is expected to price on Feb. 5.

UBS Investment Bank and Merrill Lynch & Co. are joint bookrunners on the Rule 144A/Regulation S offering.

The notes will come with four years of call protection.

The Waltham, Mass.-based manufacturer and marketer of diagnostic products for the over the counter women's test market and professional diagnostic market plans to use proceeds to refinance debt.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.